Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05055830 · ClinicalTrials.gov registry record
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
A clinical trial of Cardiac Disease and Critically Ill, sponsored by Duke University.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05055830: Recruiting study of Cardiac Disease and Critically Ill, sponsored by Duke University.
NCT05055830 is a study of Cardiac Disease and Critically Ill that is actively recruiting participants, run by Duke University. The registered enrollment target is 2,000 participants, above the 739-participant average among 24 other Cardiac Disease trials with a reported enrollment target (171% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05055830, a study of Cardiac Disease and Critically Ill, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
OPTIC is a prospective, open-label, non-randomized study of multiple medications administered to approximately 2000 children in the pediatric cardiac intensive care unit (PCICU) per routine clinical car by their treating provider. The purpose of this study is to characterize the PK of drugs routinely administered to children per standard of care using opportunistic and scavenged samples. The prescribing of drugs to children will not be part of this protocol. After the child/adult (\<21 years of age) is consented/enrolled, demographic and clinical data will be extracted from the EHR. Biospecimen information (including date and time of sample collection) will be collected. Data analysis will be conducted on all participants with at least 2 evaluable samples. The protocol represents minimal risk to the children/adults who provide body fluid for this study, including potential loss of confidentiality (samples will be assigned a unique accession number) and risks associated with blood draws. Adverse Events (AEs)/Serious Adverse Events (SAEs) caused by the study specimen collections will be monitored and recorded in the Electronic Data Capture (EDC) system.
Conditions Studied
Interventions
- DRUG The OPTIC study is collecting PK data on children prescribed understudied drugs of interest per standard of care.
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2028-10-30 |
What NCT05055830 shows while recruiting
NCT05055830 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 739-participant average among 24 other Cardiac Disease trials with a reported enrollment target (171% higher).
The record links to 3 conditions, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which The OPTIC study is collecting PK data on children prescribed understudied drugs of interest per standard of care. is the first listed.
NCT05055830 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05055830 about?
NCT05055830 is a clinical study titled "Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)". OPTIC is a prospective, open-label, non-randomized study of multiple medications administered to approximately 2000 children in the pediatric cardiac intensive care unit (PCICU) per routine clinical car by their treating provider. The purpose of this study is to characterize the PK of drugs routinel...
What is the current status of trial NCT05055830?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-10-05. Estimated completion is 2028-10-30.
What conditions does trial NCT05055830 study?
This clinical trial studies the following conditions: Cardiac Disease, Critically Ill, Children, Adult.
What interventions are being tested in trial NCT05055830?
The interventions under investigation include: The OPTIC study is collecting PK data on children prescribed understudied drugs of interest per standard of care. (DRUG).
Who is sponsoring clinical trial NCT05055830?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05055830 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05055830's enrollment target sits among peer trials
2,000 3rd of 24 higher than 22 of 24 other Cardiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
-
The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI